Granzyme B-targeted PET imaging is an alternative approach that enables detection of cytotoxic T cell activity rather than global population and correlates to melanoma and colon tumor responses during immunotherapy in preclinical studies48–50, although this imaging approach has not yet been used in glioma models. Here, GZMB is linked to central nervous system cancer.